Riskpilot← Back to searchSign inGet full accessHälsoprodukter i Dalarna AB
ABActiveOrg 5567757876Falugatan 2Retail sale of other food · NACE 4727Est. 20093 employees
Revenue 2025
SEK 5,7M
+3% vs 2024
EBITDA margin
1.4%
+64% vs 2024
Equity ratio
45.8%
Financial strength
Net profit 2025
SEK 28K
-36% vs 2024
| Revenue | SEK 5,7M | +3% |
| EBITDA | SEK 82K | +64% |
| Net profit | SEK 28K | -36% |
| Total assets | SEK 2M | -4% |
| Equity | SEK 899K | +3% |
| Employees | 3 | — |
Legal name
Hälsoprodukter i Dalarna AB
Org number
5567757876
Legal form
Aktiebolag
NACE code
4727 · Retail sale of other food
Founded
12 januari 2009
Share capital
SEK 100 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva försäljning av hälsoprodukter och terapeutisk verksamhet för människor och djur i form av akupunktur och homeopati, äga och förvalta värdepapper samt därmed förenlig verksamhet.
Address
Falugatan 2
Phone
+46243229195
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5 660 | 5 459 | 5 350 | 5 530 | 5 711 |
| Staff expenses | — | — | −885 | −896 | −950 |
| EBITDA | 599 | 362 | 130 | 50 | 82 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 599 | 362 | 130 | 50 | 82 |
| Net financials | — | — | 1 | 8 | 7 |
| Profit before tax | 530 | 362 | 30 | 58 | 39 |
| Tax | −138 | −76 | −8 | −15 | −11 |
| Net profit | 392 | 286 | 22 | 43 | 28 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 629 | 2 845 | 1 987 | 2 035 | 1 963 |
| Equity | 1 620 | 1 906 | 828 | 871 | 899 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 839 | 769 | 989 | 993 | 894 |
| Total debt | 839 | 769 | 989 | 993 | 894 |
EBITDA margin
1.4%
This company
15.8%
Market median
-91% vs market
20212025
Equity ratio
45.8%
This company
38.2%
Market median
+20% vs market
20212025
Return on equity
3.1%
This company
18.4%
Market median
-83% vs market
20212025
Net profit margin
0.5%
This company
8.1%
Market median
-94% vs market
20212025
Asset turnover
2.91×
This company
1.12×
Market median
+160% vs market
20212025
Debt / equity
1.18×
This company
0.62×
Market median
-90% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
UM Audit | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Hälsoprodukter i Borlänge AB
Hälsoprodukter i Dalarna AB Board members of Hälsoprodukter i Dalarna AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ulf Marcus Persson | Audit | 0 companies |
| Jan Nicklas Henriksson | Deputy Board Member | 0 companies |
| Kerstin Cathrine Henriksson | Board of Directors | 0 companies |